As a sponsor of the PDSS Event, Advanced Drug Development Services (ADDS) is pleased to invite you to meet us there. Dr. Irčne Fermont, EU QPPV, ADDS VP Risk Management & Pharmacovigilance, will be giving a lecture on "Good Pharmacovigilance Practices and Risk Management Plans in Europe" (Sept. 23). Feel free to contact us for further information.

The Annual Pacific Drug Safety Summit (PDSS) is an event created by BioSoteria, our partner.

The PDSS focuses on cutting edge pharmacovigilance practices such as the latest in REMS assessments, updates on changing EU regulations, the FDA Sentinel Initiative and much more. This year, the PDSS also offers you a whole day of pre-conference tutorials about clinical safety, postmarketing pharmacovigilance (PV), database solutions, risk management and PV compliance. To find out more :

About Dr. Irčne FERMONT:

Irčne FERMONT, Physician, Immuno-Hematologist and Master of Bioengineering (Ecole Centrale, Paris), has been recognized by the EMA as a European Qualified Person for Pharmacovigilance (EU-QPPV), and is Eudravigilance certified, allowing an electronic exchange of suspected adverse reaction reports. More

About ADDS:

A leading European service-provider, ADDS offers full coverage of Phase II-III and late phase studies for drugs and medical devices in Europe as well as complete Safety and Risk Management outsourced services, including the European Qualified Person Responsibility, at operational level as well as strategy & counselling.
ADDS services encompass Safety Surveillance of Drugs, Blood, Biotech products, Advanced Therapies products and Medical Devices and Clinical Trials with a focus on Oncology, CNS, Cardiology, Orphan Drugs, Medical Devices and Combination Products.
We have full subsidiary offices in Czech Republic, in Algeria and in Israel. More